Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: J Neuropathol Exp Neurol. 2009 Dec;68(12):1309–1318. doi: 10.1097/NEN.0b013e3181c22569

Figure 3.

Figure 3

(A) Gelatin zymography shows greater matrix metalloproteinase (MMP)-9 levels compared to proMMP-9 and MMP-2 levels in the parietal cortex. (B) Box plots show significantly increased MMP-9 but not proMMP-9 or MMP-2 activity in parietal cortex in mild cognitive impairment (MCI) and Alzheimer disease (AD) compared to the no cognitive impairment (NCI) group (p = 0.0094). Relative units in the Y-axis are described in Materials and Methods